Correlative expression of cyclooxygenase-1 (Cox-1) and human epidermal growth factor receptor type-2 (Her-2) in endometrial cancer

Kobe Journal of Medical Sciences

Volumn 53, Issue 5, 2007, Pages 177-187

  Sugimoto, Takeshi ^a,b   Koizumi, Tamio ^a   Sudo, Tamotsu ^a   Yamaguchi, Satoshi ^a   Kojima, Atsumi ^a   Kumagai, Shunichi ^b   Nishimura, Ryuichirou ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclooxygenase 1 (Cox 1); Cyclooxygenase 2 (Cox 2); Endometrial cancer; Human epidermal growth factor receptor type 2 (Her 2); Vascular endothelial growth factor (VEGF)

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; VASCULOTROPIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER INVASION; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MYOMETRIUM; OUTCOME ASSESSMENT; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SAMPLE;

ADENOCARCINOMA; ADULT; AGED; CELL LINE, TUMOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; ISOENZYMES; MIDDLE AGED; RECEPTOR, ERBB-2; RNA, MESSENGER;

EID: 39649112898     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Arango, H.A., Icely, S., Roberts, W.S., Cavanagh, D., Becker, J.L. 2001. Aspirin effects on endometrial cancer cell growth. Obstet Gynecol. 97: 423-427.
2. Bauer, A.K., Dwyer-Nield, L.D., Malkinson, A.M. 2000. High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis. 21: 543-550.
3. Benoit, V., Relic, B., Leval, Xd. X., Chariot, A., Merville, M.P., Bours, V. 2004. Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2. Oncogene. 23: 1631-1635.
4. Buckley, A.R. 2001. Lessons from anticancer research might provide new insights into mechanisms of hormone action. Trends Endocrinol Metab 12: 87-89.
5. Church, R.D., Fleshman, J.W., McLeod, H.L. 2003. Cyclo-oxygenase 2 inhibition in colorectal cancer therapy. Br J Surg. 90: 1055-1067.
6. Daikoku, T., Wang, D., Tranguch, S., Morrow, J.D., Orsulic, S., DuBois, R.N., Dey, S.K. 2005. Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 65: 3735-3744.
7. Denkert, C., Kobel, M., Pest, S., Koch, I., Berger, S., Schwabe, M., Siegert, A., Reles, A., Klosterhalfen, B., Hauptmann, S. 2002. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol. 160: 893-903.
8. Dore, M., Cote, L.C., Mitchell, A., Sirois, J. 1998. Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas. J Histochem Cytochem. 46: 77-84.
9. Esteller, M., Xercavins, J., Reventos, J. 1999. Advances in the molecular genetics of endometrial cancer (Review). Oncol Rep. 6: 1377-1382.
10. Ferrandina, G., Legge, F., Ranelletti, F.O., Zannoni, G.F., Maggiano, N., Evangelisti, A., Mancuso, S., Scambia, G., Lauriola, L. 2002. Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome. Cancer. 95: 801-807.
11. Ferrandina, G., Ranelletti, F.O., Gallotta, V., Martinelli, E., Zannoni, G.F., Gessi, M., Scambia, G. 2005. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. Gynecol Oncol. 98: 383-389.
12. Fujiwaki, R., Iida, K., Kanasaki, H., Ozaki, T., Hata, K., Miyazaki, K. 2002. Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Hum Pathol. 33: 213-219.
13. Gupta, R.A., Tejada, L.V., Tong, B.J., Das, S.K., Morrow, J.D., Dey, S.K., DuBois, R.N. 2003. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res. 63: 906-911.
14. Half, E., Tang, X.M., Gwyn, K., Sahin, A., Wathen, K., Sinicrope, F.A. 2002. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res. 62: 1676-1681.
15. Hoskins, W., Perez, C., Young, R. 2000. Principles and practice of gynecologic oncology. Philaderphia: Lippincortt Williams and Wilkins;
16. Howe, L.R., Subbaramaiah, K., Patel, J., Masferrer, J.L., Deora, A., Hudis, C., Thaler, H.T., Muller, W.J., Du, B., Brown, A.M., Dannenberg, A.J. 2002. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res. 62: 5405-5407.
17. Jabbour, H.N., Milne, S.A., Williams, A.R., Anderson, R.A., Boddy, S.C. 2001. Expression of COX-2 and PGE synthase and synthesis of PGE(2)in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br J Cancer. 85: 1023-1031.
18. Kim, M.H., Seo, S.S., Song, Y.S., Kang, D.H., Park, I.A., Kang, S.B., Lee, H.P. 2003. Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes. Gynecol Oncol. 90: 83-90.
19. Kino, Y., Kojima, F., Kiguchi, K., Igarashi, R., Ishizuka, B., Kawai, S. 2005. Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2. Prostaglandins Leukot Essent Fatty Acids. 73: 103-111.
20. Landen, C.N.Jr., Mathur, S.P., Richardson, M.S., Creasman, W.T. 2003. Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. Am J Obstet Gynecol. 188: 1174-1176.
21. Lax, S.F. 2004. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch. 444: 213-223.
22. Li, S., Miner, K., Fannin, R., Carl Barrett, J., Davis, B.J. 2004. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium. Gynecol Oncol. 92: 622-627.
23. Munkarah, A., Miller, B. 2003. Cyclooxygenase-2: a novel target for cancer prevention and treatment. Woman's Oncol Rev 3:15-24.
24. Narko, K., Ristimaki, A., MacPhee, M., Smith, E., Haudenschild, C.C., Hla, T. 1997. Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression. J Biol Chem. 272: 21455-21460.
25. Oehler, M.K., Brand, A., Wain, G.V. 2003. Molecular genetics and endometrial cancer. J Br Menopause Soc 9: 27-31.
26. Okamoto, T., Hara, A., Hino, O. 2003. Down-regulation of cyclooxygenase-2 expression but up-regulation of cyclooxygenase-1 in renal carcinomas of the Eker (TSC2 gene mutant) rat model. Cancer Sci. 94: 22-25.
27. Pruthi, R.S., Derksen, E., Gaston, K. 2003. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review. J Urol. 169: 2352-2359.
28. Ristimaki, A., Sivula, A., Lundin, J., Lundin, M., Salminen, T., Haglund, C., Joensuu, H., Isola, J. 2002. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 62: 632-635.
29. Roland, I.H., Yang, W.L., Yang, D.H., Daly, M.B., Ozols, R.F., Hamilton, T.C., Lynch, H.T., Godwin, A.K., Xu, X.X. 2003. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies. Cancer. 98: 2607-2623.
30. Sales, K.J., Jabbour, H.N. 2003. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction. 126: 559-567.
31. Sales, K.J., Katz, A.A., Howard, B., Soeters, R.P., Millar, R.P., Jabbour, H.N. 2002. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res. 62: 424-432.
32. Sanchez-Alcazar, J.A., Bradbury, D.A., Brea-Calvo, G., Navas, P., Knox, A.J. 2003. Camptothecin-induced apoptosis in non-small cell lung cancer is independent of cyclooxygenase expression. Apoptosis. 8: 639-647.
33. Sherbet, G.V., Patil, D. 2003. Genetic abnormalities of cell proliferation, invasion and metastasis, with special reference to gynaecological cancers. Anticancer Res. 23: 1357-1371.
34. Smith, M.L., Hawcroft, G., Hull, M.A. 2000. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer 36: 664-674.
35. Takeda, H., Sonoshita, M., Oshima, H., Sugihara, K., Chulada, P.C., Langenbach, R., Oshima, M., Taketo, M.M. 2003. Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis. Cancer Res. 63: 4872-4877.
36. Tong, B.J., Tan, J., Tajeda, L., Das, S.K., Chapman, J.A., DuBois, R.N., Dey, S.K. 2000. Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia. 6: 483-490.